APUS

APIMEDS PHARMACEUTICALS US INC

3.21

0.42+15.05%

After Hours: 3.180 -0.03 -0.93%19:15 11/14 EST

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE2.760/2.790

TODAY RANGE2.759-3.330

VOL99.66K

MARKET CAP40.37M

52 WEEK RANGE1.370-4.000

AVG VOL (3M)128.07K

% TURNOVER0.79%

TURNOVER--

P/E (TTM)-6.7423

% RANGE20.47%

EPS(TTM)-0.4761

P/E(FORWARD)--

P/B4.947

BVPS0.6489

DIVIDEND--

P/S--

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP9.91M

SHARES OUTSTANDING12.58M

NEXT EARNINGS--

FREE FLOAT3.09M

LOT SIZE1

EX-DATE--

News

Press Releases

Financial Reports

Profile

TipRanks·10/16 20:54
Apimeds Pharmaceuticals Amends Bylaws for Shareholder Consent
TipRanks·10/14 09:30
Apimeds Pharmaceuticals expands AI Futures Lab program
TipRanks·09/12 09:20
Apimeds Pharmaceuticals issues statement on FDA draft guidance for pain program
TipRanks·08/14 22:28
Apimeds Pharmaceuticals Delays 10-Q Filing
TipRanks·07/16 10:48
Apimeds Pharmaceuticals Expands Leadership with Key Appointments
Dow Jones·07/15 21:34
*Apimeds Expands Leadership Team With Susan Kramer to Lead Pdt Development and Brian Peters to Lead Its Ai(2) Division
TipRanks·06/05 20:33
Apimeds Pharmaceuticals Appoints Erick J. Frim as CFO
TipRanks·05/30 18:45
Opening Day: Pitanium opens for trading in slow week for IPOs
TipRanks·05/20 11:58
Apimeds Pharmaceuticals Amends Promissory Notes Terms
TipRanks·05/16 02:13
Top Executive Makes Bold Move with Major Stock Purchase!
TipRanks·05/15 22:27
Apimeds Pharmaceuticals Delays Quarterly Report Filing
TipRanks·05/15 02:06
Major Investments Pour into Apimeds Pharmaceuticals!
TipRanks·05/12 21:49
Apimeds Pharmaceuticals US, Inc. Completes Successful IPO
NASDAQ·05/12 21:20
Apimeds Pharmaceuticals US, Inc. Completes Initial Public Offering, Raising $13.5 Million for Clinical Development
Seeking Alpha·05/10 04:15
U.S. IPO Weekly Recap: Sizable Insurance IPOs Deliver Solid Trading

Same Industry

Name/Symbol

Change%

Price

Regeneron Pharmaceuticals

REGN

-0.21%

693.50

Entero Therapeutics

ENTO

+2.72%

3.77

BIONTECH

BNTX

-0.76%

103.09

United Therapeutics Corp.

UTHR

+0.89%

466.40

Vertex Pharmaceuticals Inc

VRTX

+0.61%

437.15

Siga Technologie

SIGA

-1.32%

6.00

Moderna

MRNA

-0.76%

24.77

Charles Riv Labs Intl Inc

CRL

-0.83%

167.81

Medpace Holdings

MEDP

-0.21%

590.09

Talphera Inc

TLPH

+19.05%

1.25

ICON PLC

ICLR

-0.78%

162.18

China Biologic

CBPO

119.99

Iqvia Hldgs Inc

IQV

-1.32%

220.61

MOLECULAR PARTNERS AG

MOLN

-1.40%

4.22

Arcturus Therape

ARCT

-6.44%

7.27

Gilead Sciences Inc

GILD

-0.14%

125.02

PRA Health

PRAH

165.21

Incyte Corp

INCY

-1.20%

104.15

Aptevo Therapeutics Inc

APVO

-2.76%

1.41

Biospecifics

BSTC

+0.15%

88.53

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.